Download App
PAPER TRADE
Download App
Login
Feedback
SUNPHARMA
newsbot
Reputation: 200,298 •
May 29, 2020 9:28 PM
Sun Pharma gains 5% on DGCI nod to initiate clinical trial of drug on COVID-19 patients
Nafamostat is approved in Japan for improvement of acute symptoms of pancreatitis and treatment of Disseminated Intravascular Coagulation (DIC).
Moneycontrol
https://www.moneycontrol.com/news/business/markets/sun-ph...
#SUNPHARMA
Vote
Comment
Share
NSE:SUNPHARMA price when posted: 478.05